EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,831 | -63.9% | 22,400 | -16.7% | 0.00% | – |
| Q2 2023 | $18,937 | -76.2% | 26,900 | -69.7% | 0.00% | – |
| Q1 2023 | $79,688 | -52.9% | 88,850 | -38.4% | 0.00% | – |
| Q4 2022 | $169,186 | -87.9% | 144,250 | -22.5% | 0.00% | -100.0% |
| Q3 2022 | $1,400,000 | +54.9% | 186,050 | +29.7% | 0.00% | +50.0% |
| Q2 2022 | $904,000 | -4.2% | 143,450 | +26.0% | 0.00% | 0.0% |
| Q1 2022 | $944,000 | +84.4% | 113,850 | +15.4% | 0.00% | +100.0% |
| Q4 2021 | $512,000 | -23.2% | 98,650 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $667,000 | -12.7% | 99,750 | +11.1% | 0.00% | -50.0% |
| Q2 2021 | $764,000 | +14.4% | 89,750 | +19.0% | 0.00% | 0.0% |
| Q1 2021 | $668,000 | -2.8% | 75,400 | +34.9% | 0.00% | 0.0% |
| Q4 2020 | $687,000 | +64.7% | 55,900 | +9.2% | 0.00% | +100.0% |
| Q3 2020 | $417,000 | +10325.0% | 51,200 | +12700.0% | 0.00% | – |
| Q2 2020 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |